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Abstract
Background—Epidemiological surveys indicate that occupants of mold contaminated 
environments are at increased risk of respiratory symptoms. The immunological mechanisms 
associated with these responses require further characterization.
Objective—The aim of this study was to characterize the immunotoxicological outcomes 
following repeated inhalation of dry Aspergillus fumigatus spores aerosolized at concentrations 
potentially encountered in contaminated indoor environments.
Methods—A. fumigatus spores were delivered to the lungs of naïve BALB/cJ mice housed in a 
multi-animal nose-only chamber twice a week for a period of 13 weeks. Mice were evaluated at 24 
and 48 hours post-exposure for histopathological changes in lung architecture, recruitment of 
specific immune cells to the airways, and serum antibody responses.
Result—Germinating A. fumigatus spores were observed in lungs along with persistent fungal 
debris in the perivascular regions of the lungs. Repeated exposures promoted pleocellular 
infiltration with concomitant epithelial mucus hypersecretion, goblet cell metaplasia, subepithelial 
fibrosis and enhanced airway hyperreactivity. Cellular infiltration in airways was predominated by 
CD4+ T cells expressing the pro-allergic cytokine IL-13. Furthermore, our studies show that 
antifungal T cell responses (IFN-γ+ or IL-17A+) co-expressed IL-13, revealing a novel mechanism 
for the dysregulated immune response to inhaled fungi. Total IgE production was augmented in 
animals repeatedly exposed to A. fumigatus.
Conclusions & Clinical Relevance—Repeated inhalation of fungal aerosols resulted in 
significant pulmonary pathology mediated by dynamic shifts in specific immune populations and 
their cytokines. These studies provide novel insights into the immunological mechanisms and 
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targets that govern the health outcomes that result from repeated inhalation of fungal bioaerosols 
in contaminated environments.
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INTRODUCTION
Potential adverse health outcomes from fungal bioaerosols in contaminated buildings is of 
growing concern in the general population [1-3]. Consensus documents published by the 
Institute of Medicine (IOM) and the World Health Organization (WHO) have identified 
epidemiological associations between the presence of indoor mold contaminants and 
respiratory health effects [4, 5]. Recent updates to these documents have emphasized causal 
associations between fungal exposure and asthma exacerbations [6]. Fungal exposures can 
be significantly higher in water damaged indoor environments or in certain occupational 
environments such as agriculture and wood processing [7]. In mold contaminated indoor 
environments such as schools and offices, a concern for chronic exposure to molds exists [8, 
9]. In such circumstances, individuals may be exposed to multiple fungal components such 
as spores, fragments, allergens, mycotoxins, and microbial volatile organic compounds 
(MVOCs) at varying rates depending on the extent of contamination.
Fungal spores or conidia of a respirable size gain access to deep pulmonary regions and are 
efficiently neutralized without excessive inflammatory damage [10]. However, in 
environments with excessive fungal contamination, exposures may be significantly higher 
resulting in robust inflammatory responses. Chronic exposure to fungal particles can 
exacerbate pre-existing respiratory distress and lead to rhinitis, asthma, and allergic diseases 
[11-14]. The impact of chronic exposures on human respiratory health and the 
immunopathological mechanisms that lead to allergic inflammation are poorly understood. 
Studies that model the normal exposure routes and the burden of fungi encountered in the 
environment are also lacking.
To date, most animal studies of fungal exposure have characterized pulmonary responses to 
liquid suspensions of spores or crude antigenic extracts in animals pre-sensitized to fungal 
antigens [15, 16]. These methods do not replicate an environmental exposure to fungal 
bioaerosols and do not consistently reproduce the pulmonary pathology associated with 
chronic exposures [17]. These methods instantaneously deliver a large bolus of spores that 
could potentially form agglomerates in the airways and influence the ensuing immune 
responses [18].
Recently, studies showed that exposure to dry fungal bioaerosols using a nose-only 
inhalation chamber resulted in significant expansion of the adaptive arm of the immune 
response in experimental animals [17, 19]. However, limitations in controlling the dose of 
inhaled fungal particles and the use of anesthesia may restrict an accurate assessment of the 
impact of natural fungal deposition in the lungs and limit the understanding of the 
underlying immunopathological mechanisms.
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To address these methodological limitations, we developed an acoustical generator system 
(AGS) for delivering dry aerosolized fungal spores to mice housed in a multi-animal 
exposure chamber [20]. Aerosolized spores are delivered into a nose-only inhalation 
chamber, where mice inhale the spores. The system is equipped with a calibrated 
aerodynamic particle sizer that allows for real-time computation of particle size, 
concentration, estimated deposition, and adjustment of the lung deposition dose. In a recent 
report on short-term inhalational exposures of mice (4 weeks) to A. fumigatus, we observed 
significant recruitment of immune cells to the airways, dominated by a unique population of 
CD8+IL-17A+ (Tc17) T-cells [20]. In the present report, we expand those findings to address 
the pulmonary pathological responses associated with 13-week subchronic exposures and 
report the dynamic changes in recruitment of various immune cell populations associated 
with anti-fungal responses and allergic inflammation. The observations provide a better 
understanding of how the pulmonary response to molds may be regulated under long term 
exposure scenarios that typically represent a contaminated indoor environment.
METHODS
Animals, fungal cultures and exposures
Five week old female BALB/cJ mice were purchased from The Jackson Laboratory (Bar 
Harbor, ME) and housed in the NIOSH animal facility. All animal procedures were reviewed 
and approved by the NIOSH Animal Care and Use Committee (ACUC).
Aspergillus fumigatus B-5233 (gift from Dr. June Kwon-Chung, NIAID/Bethesda, MD) 
spores enriched on malt extract agar and after 7-14 days spores were harvested and 
resuspended in filter sterilized; endotoxin-free water (Sigma Aldrich, St. Louis, MO) and 
inoculated on autoclaved rice and cultured for 2 weeks.
Mice were separated into 3 exposure groups: 1) HEPA filtered air only (Control); 2) 1 × 104 
A. fumigatus spores; or 3) 1 × 105 A. fumigatus spores. These doses represent the estimated 
deposited spores in lungs of animals for each exposure. Mice were exposed twice a week for 
a total of 13 weeks (total 26 exposures) using the Acoustical Generator System (AGS) as 
previously described [20]. The system is programmed to automatically shut off the spore 
supply when the desired dose of lung deposition has been achieved [20, 21]. Post-exposure 
exposure time points were selected to evaluate histopathological changes in the lung and for 
differential analysis of immune cells in murine tissues [20]. For airway hyperreactivity 
studies and serum antibody analysis, mice were sacrificed at varying time points post final 
exposures. Mice were euthanized via intraperitoneal injection of sodium pentobarbital 
solution (Sleepaway®, Fort Dodge, IA).
Histopathological assessment
Lung tissues were embedded in paraffin and sections were stained with hematoxylin and 
eosin (H&E), alcian blue/periodic acid-Schiff (AB/PAS) stain or Masson's trichrome stain. 
Fungal deposition in lungs was determined by Grocott's methenamine silver (GMS) staining. 
Total and germinating spores in GMS stained sections were quantified as previously 
described [20]. Spores > 3 μm in size were classified as swollen, suggesting germination.
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Flow cytometry and differential analysis
Bronchoalveolar lavage fluid (BALF) and mediastinal lymph node (MLN) cell suspensions 
were prepared using previously described methods [20]. Cell suspensions for intracellular 
cytokine staining (ICS) were activated using Leukocyte activation cocktail with BD 
GolgiPlug™ (BD Biosciences). Prior to staining, Fc receptors were blocked by incubation in 
a cocktail containing unlabeled anti-CD16/CD32 (Fc block; BD Biosciences, San Diego, 
CA) and rat serum in FACS buffer (Dulbecco's phosphate buffered saline containing 5% 
fetal calf serum and 0.0005% sodium azide). For staining, fluorochromeconjugated 
antibodies such as PerCP-CD45, PE-Siglec-F, FITC-Ly-6G, V500-CD3ε, PE-CD45R/B220, 
AF700-CD4, APC-H7-CD8α, V500-CD45R/B220, BV421-CD25, APC-IL-5, PE-CF594-
IFN-γ, AF647-IL-9 (all BD Biosciences, San Diego, CA), APC-CD11c, PE-IL-13, PerCP-
EF710-IL-22 (all eBioscience, San Diego, CA), Pe-Cy7-IL-10, BV605-IL-17A (all 
BioLegend, San Diego, CA) were used per manufacturer's recommendations. Following 
surface staining, cell suspensions were fixed in BD CytoFix (BD Biosciences) prior to 
differential analysis of constituent populations or for ICS staining.
For differential analysis of BALF cell populations, leukocytes were first identified based on 
CD45 expression and then differentiated using a previously described strategy [22]. 
Neutrophils were identified as Ly-6G+ population. Ly-6G− cells were further separated 
based on expression of Siglec-F and CD11c. Eosinophils were identified as CD11clowSiglec-
Fhigh populations. Alveolar macrophages were identified as CD11chighSiglec-F+ populations 
on their autofluorescence profiles [23]. Lymphocytes were further differentiated based on 
expression of CD4 and CD8, while B cells were identified based on the expression of 
CD45R/B220. Within the lymphocyte subset in the BALF, cells with a surface phenotype 
CD4−CD8−B220−CD25+ were defined as non-B non-T cell population (NBNT) and 
evaluated for cytokine expression profile. BALF (50,000 total events) and MLN (100,000 
total events) cell populations were evaluated and differentiated using a BD LSRII flow 
cytometer system (BD Biosciences). Analysis of flow cytometry data was conducted using 
FlowJo v 7.6.5 software (Tree Star, Inc., Ashland, OR).
ELISA and Western blot analysis
Blood was collected at euthanasia in Microtainer serum separation tubes (BD Pharmingen, 
Franklin Lakes, NJ) and centrifuged to obtain serum. Total IgG1 and IgG2a in pooled sera 
were determined using standard methodologies described previously [24]. Serum IgE was 
estimated in pooled sera using a mouse IgE ELISA MAX™ kit as per manufacturer's 
instructions (BioLegend). A. fumigatus spore and hyphal extracts were generated using 
previously described methods [20, 25].
Airway hyperreactivity (AHR) Methodology
AHR assessment was conducted in BALB/cJ mice at 10 days post final exposure as 
previously described [26]. Briefly, mice were placed in Buxco whole body plethysmography 
chambers and baseline enhanced pause (Penh) values obtained. Mice were then sequentially 
challenged by nebulizing increasing concentrations (10, 25 and 50 mg/ml) of methacholine 
and Penh values determined.
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Statistical differences between groups were evaluated by the test of analysis of variance 
(ANOVA) using SAS software. A Nonparametric Wilcoxon Rank Sum test was conducted to 
analyze total fungal counts and fungal germination data. For all graphs, *p < 0.05, **p < 
0.0001 and n = 10 mice/group. Significance values are in comparison to control animals 
within the same time point, unless specifically noted.
RESULTS
Aerosolization and pulmonary deposition of A. fumigatus spores
The average aerodynamic diameter of aerosolized spores was 2.25 μm and spores were 
predominantly homogenous (Figures 1A and 1B). Mice from all exposure groups gained 
weight during the course of exposure interval (Figure 1C). Fungal deposition in murine 
lungs was multifocal and spores were readily observed in animals receiving 105 compared to 
104 spores, with a higher spore burden observed at 24 hrs (Figure 1D). No fungal spores 
were observed in control animals. The presence of swollen spores and germ tube formation, 
particularly in animals exposed to the higher dose was suggestive that spores were in the 
process of germination (Figures 1E and 1F). Spores were primarily localized in the lung 
interstitium (Figure 1E), where staining was also observed for fungal debris. A pronounced 
staining was noted for fungal debris around the pulmonary blood vessels (Figure 1G). 
Although germination of A. fumigatus was observed, there was no evidence of extensive 
pulmonary colonization or invasive disease.
Pulmonary inflammation on repeated inhalation of spores
Inhalation of A. fumigatus spores resulted in a dose-dependent and multifocal peribronchial 
and perivascular inflammation characterized by pleocellular infiltration inclusive of 
mononuclear phagocytes, granulocytes and lymphocytes (H&E staining) (Figure 2A). This 
inflammatory response was most prominent in the bronchioles. Cellular infiltration was also 
prominent in the lung parenchyma surrounding the airways, and highlighted by significant 
alveolitis.
Exposure to fungal spores stimulated mucus production by the airways epithelial cells that 
was more pronounced at the 105 dose (Figures 2A and 2B). PAS staining demonstrated 
dose-dependent differences in goblet cell metaplasia in the bronchioles, and mice treated 
with the higher dose had larger numbers of cells with mucinogen granules (Figure 2B). 
Subepithelial fibrosis was assessed by trichrome staining and showed increased interstitial 
collagen deposition beneath the basement membrane of the airway epithelial cells (Figure 
2A). Collagen deposition was prominent in regions of the lung that exhibited robust cellular 
infiltration.
Changes in the bronchial architecture were accompanied with minimal pulmonary arterial 
remodeling (Supplementary Figure S1A). Smaller blood vessels in close proximity to the 
bronchioles showed minimal narrowing of the lumina. Evidence of remodeling with 
collagen deposition was associated with increased cellular infiltration around blood vessels 
and was strongest in mice dosed with 105 spores. Remodeling that resulted in nearly 
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complete closure of the blood vessel lumen was rare and only observed in mice at the 105 
dose (Supplementary Figure S1B). Blood vessels that demonstrated signs of remodeling 
typically showed perivascular deposition of fungal debris.
Cellular composition of airways indicate an allergic phenotype
Flow cytometric characterization of the cellular infiltrate in the airways demonstrated that 
subchronic inhalation of A. fumigatus spores increased recruitment of leukocytes to the 
airways (Figure 3A). A proportional reduction in alveolar macrophages (AMΦ) was 
observed in mice dosed with spores (Figure 3B). Infiltration by neutrophils and eosinophils 
increased significantly in a dose-dependent fashion and the former comprised the dominant 
innate cell population in the airways.
Repeated inhalation of fungal spores promoted the recruitment of adaptive immune cells to 
the inflamed airways (Figure 3C). The total number of CD4+ (TH) cells was significantly 
increased following the final exposure and by 48 hours formed the dominant cell population 
among all immune cells present in the airways. The total numbers of TH cells recruited to 
airways was independent of the delivered dose in mice. The influx of CD8+ T cells into the 
airways was minor. Although the recruitment of B cells significantly increased in mice 
dosed with 104 spores from 24 to 48 hrs, their recruitment to the airways was significantly 
lower compared to mice exposed to 105 spores.
Collectively these results demonstrate that repeated inhalation of A. fumigatus spores 
resulted in the formation of a mixed immune response in the airways; with significant dose-
dependent differences in the recruitment of neutrophils, eosinophils and B cells. Other innate 
and adaptive responses did not significantly differ in animals exposed to different doses of 
fungal spores over a period of 13 weeks.
Recruitment of T cells with diverse cytokine expression profiles
Adaptive immune cells recruited to the airways secrete various mediators following 
inhalation of fungi and contribute to changes in pulmonary architecture and pathology. To 
further define the T-cell immune responses, intracellular cytokine expression profiles were 
examined using flow cytometry. A complex mixture of TH1, TH2, TH17 and TH22 cells was 
observed in the airways with significantly elevated numbers of IL-13+CD4+ T cells (TH2) 
indicating a dominant allergic response (Figure 3D and Supplementary Figure S2). This 
robust expansion in the number of TH cells expressing IL-13 demonstrated both, an increase 
in the mean fluorescence intensity (MFI) for IL-13 and dose-dependent differences that were 
significant at 48 hours (Figure 3E). CD4+ T cells that expressed the pro-inflammatory 
cytokine IFN-γ (TH1) were identified as the second largest TH population. The recruitment 
of CD4+ T cells expressing the pro-inflammatory cytokine IL-17A (TH17) cells was 
significantly increased between doses. The TH17 cells did not express IFN-γ (data not 
shown) and hence represent the regulated “classical” TH17 subpopulation [27]. IL-22 
expressing CD4+ T cells (TH22) were recruited to the airways and their numbers were 
comparable to TH17 cells (Figure 3D). Furthermore, >95% of IL-22 expressing CD4+ T 
cells did not co-express IL-17A (Figure 3F) and were thus identified as a TH22 cell 
population. TH22 cells have been previously reported to be important in anti-microbial host 
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defense, in limiting mucosal inflammation and in playing a role in tissue repair following 
repeated microbial insult [28, 29].
TH cells expressing IFN-γ, IL-17A and IL-22 drive pulmonary anti-fungal responses by 
recruiting innate cells and promoting sequestration of inhaled fungal spores. We analyzed 
the expression of IL-13 in CD4 T cells expressing IFN-γ (Figures 4A - 4C) or IL-17A 
(Figures 4D - 4F) or IL-22 (Figures 4G - 4I). We observed that TH1 (30-40%), TH17 
(25-35%) and TH22 (10-20%) cells expressed the pro-allergenic TH2 cytokine IL-13 in a 
dose-dependent fashion although dose-dependent differences were not significant. The mean 
fluorescence intensity for IL-13 expression in these subpopulations was significantly 
different between doses at 24 hours (TH17 only) and 48 hours (for all subpopulations).
In the MLNs, B cells constituted the largest cell population followed by CD4+ T cells 
(Supplementary Figure S3A). Expansion of both populations was greater in animals 
repeatedly dosed to 105 spores. Significant differences were demonstrated in the number of 
CD8+ T cells in the MLNs. The cytokine profile of CD4+ and CD8+ T cells largely 
paralleled that of the subpopulations in the BALF. Among CD4+ T cells, IL-13 expressing 
cells along with IL-9 expressing cells formed the largest populations followed by IL-22, 
IFN-γ, IL-10 and then IL-17A expressing populations (Supplementary Figure S3B), while 
most CD8+ T cells expressed IFN-γ (Supplementary Figure S3C).
Collectively, these results show that IL-13 responses dominate the airways of animals that 
repeatedly inhaled fungi, and dose-dependent differences were not significant; although 
increased expression of IL-13 was observed in recruited TH cells. Furthermore, the plasticity 
of the anti-fungal T cell responses also appeared to contribute towards the total IL-13 pool, 
thus identifying a novel mechanism driving the allergic responses.
Antibody responses to repeated inhalation of spores
Repeated inhalation of spores stimulated IgG and IgE antibody production in A. fumigatus 
exposed mice (Figure 5). A significant increase in total serum IgE levels was observed, 
which continued to increase 2 weeks after the completion of fungal exposures (Figure 5A). 
Serum IgE concentrations were also distinctly elevated in animals receiving the higher dose 
of the respirable fungal spores.
Elevated levels of IgG1 and IgG2a serum antibodies are associated with TH2 and TH1 
responses respectively. An IgG2a/IgG1 ratio of >1 is supportive of the TH1 type of response, 
while a ratio of <1 is indicative of a TH2 type response. This ratio was consistently >1 at 
both time points in animals dosed with 104 spores (Figure 5B). In contrast, exposure of 
mice to 105 spores resulted in a ratio of <1 following, suggesting a shift to an allergic 
phenotype.
Inhalation of A. fumigatus results in enhanced AHR
In order to determine the impact of elevated allergic responses in the airways, we assessed 
airway hyperreactivity in mice at 10 days post final exposures (Figure 5C). Repeated 
inhalation of A. fumigatus by mice over a period of 13 weeks resulted in enhanced airway 
hyperresponsiveness to aerosolized methacholine with dose-dependent differences at 50 
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mg/ml methacholine after 10 days following the final exposure. All data points reflect values 
relative to baseline values determined with no methacholine challenge.
DISCUSSION
Mold contamination in damp indoor environments and the exacerbation of adverse 
respiratory health effects has gained significant attention in recent times. To date, few 
murine exposure models have replicated mold exposures that would be encountered in the 
environment. Furthermore, the broad diversity of various molds poses significant challenges 
in evaluating toxicity. To overcome these limitations, NIOSH has developed an exposure 
system that allows the study of the health effects resulting from the inhalation of fungal 
bioaerosols.
Short term A. fumigatus spore inhalation exposures (4 weeks) were found to induce an acute 
inflammation highlighted by a notable CD8+IL-17A+ (Tc17) response that correlated with in 
vivo spore germination [20]. In the present study, subchronic exposures (13 weeks) in naïve 
animals skewed the immune response toward an allergic phenotype resulting in significant 
expansion of diverse subpopulations of CD4+ T cells and Tc17 cells no longer detectable. 
Our results additionally demonstrate that a small proportion of inhaled spores were in the 
process of germination in the lungs. During in vitro assessments, it has been shown that 
germinated fungal spores release greater quantities of allergens than un-germinated fungal 
spores [30]. This process may provide persistent antigenic stimulation in situ, influence the 
dynamic nature of pathogen recognition and promote the expansion of adaptive immune 
responses in the pulmonary environment.
Chronic inflammation following exposure to A. fumigatus spores for 13 weeks was 
characterized by the influx of a complex mixture of cells that expressed cytokines associated 
with TH1, TH2, TH17 and TH22 responses. Most CD4+ T cells expressed IL-13, the hallmark 
cytokine of the TH2 response and a central mediator of allergic inflammation and airway 
diseases. Allergic disease features consistent with IL-13 effector functions [31], such as 
increased eosinophilia, isotype switching in B cells, IgE production, mucus secretion, goblet 
cell metaplasia, pulmonary tissue remodeling, enhanced airway hyperreactivity and 
subepithelial fibrosis were observed. Fibrosis resulting from inefficient clearance of a 
pathogen and its related constituents causes persistent and ineffective chronic inflammation 
and injury [32]. Persistence of intact fungi and fungal debris post exposures may be a 
contributing factor in the current study. The allergic response is also likely to be supported, 
in part, by T cells expressing the cytokines, IL-5 and IL-9.
Recent reports describe plasticity among TH17 and transitional stage TH1 effector 
populations in secreting IL-13 in mice and humans in response to foreign antigens [33-36]. 
This plasticity is owed to alternative transcription factor usage by antigen presenting cells 
that promote re-programming of TH1 and TH17 cells to secrete TH2 cytokines. Using 
intracellular cytokine staining to characterize co-expression of cytokines by individual cells, 
our studies show that an appreciable fraction of TH1 and TH17 cells produce IL-13 in vivo 
following repeated exposures to A. fumigatus spores. This is a critical finding as it 
demonstrates that a significant fraction of T cells that drive anti-fungal responses, also 
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contribute to the allergic outcomes. Identifying specific antigen presenting subpopulations 
driving the polarization signals resulting in mixed anti-fungal/allergy phenotype in these T 
cells could provide insight into how allergic diseases to fungi develop.
Collectively, our studies used significantly lower doses than previous animal models of 
fungal exposures [10, 37] and showed that repeated inhalation of fungal aerosols can result 
in dysregulation of immunological mediators impacting the pulmonary architecture and 
function. This may be due to the adaptive antifungal responses that contribute towards the 
development of allergic disease. However, ILCs and more specifically inflammatory ILC2s 
may in part contribute to the overall dysregulation [16, 38, 39]. These studies emphasize the 
role of pulmonary innate recognition of inhaled fungal spores in providing composite signals 
for promoting fungal clearance and allergic responses. Furthermore, fungal germination was 
identified in the lungs of exposed mice and highlight an additional source of antigenic 
stimulation that could contribute towards development of allergic inflammation. The results 
of this study suggest that personal exposure to low doses of fungal bioaerosols for long 
durations can result in the development of allergic responses involving moderate airway 
inflammation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Spore dispersal, animal weights and spore germination in vivo
A. Graph representing mean size of particles aerosolized during exposure. All aerosolized 
spores were under 3 μm in size. B. Scanning electron microscope (SEM) image of 
aerosolized Aspergillus fumigatus spores deposited on a polycarbonate filter. C. Effect of 
repeated exposures to A. fumigatus spores on whole animal body weight. Control (●), 104 
A. fumigatus spores (○) and105 A. fumigatus spores (▲) (n = 28-30 mice per group). D. 
Total A. fumigatus spore counts post exposure. Exposure groups - 104 spores (grey bars) and 
105 spores (black bars) (n=2-3). E. Percentage of A. fumigatus spores germinating post 
exposure (n=2-3). F. Representative micrograph of GMS stained section from animal dosed 
with 105 spores at 24 hr post exposure (n=2-3). Black arrows point to germinating spores. 
Magnification: 100X objective and bar size = 20 μm. G. Micrograph of GMS stained section 
from animal dosed with 105 spores, 24 hrs post exposure showing perivascular deposition of 
fungal debris (black arrows) (n=2-3). Magnification: 60X objective and bar size = 20 μm.
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Figure 2. Repeated inhalation of fungal spores causes allergic pulmonary inflammation and 
changes in pulmonary airway architecture
A. Representative stained lung tissue sections from animals at 24 and 48 hrs post final 
exposure. Magnification: 20X objective for H&E and AB/PAS stained sections and 100X for 
Trichrome stained sections (n=2-3). B. Representative AB/PAS stained lung sections 
generated from right lungs of animals, excised at 24 and 48 hrs post final exposure (n=2-3). 
Magnification: 40X objective. H&E – hematoxylin and eosin. AB/PAS – alcian blue/
periodic acid-Schiff. Bar size – 50 μm (H&E and AB/PAS staining) and 20 μm (Trichrome 
staining).
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Figure 3. Exposure to dry aerosols of A. fumigatus spores promotes infiltration by immune cells 
in the airways
A. Recruitment of leukocytes, B. alveolar macrophages (AMΦ), neutrophils and eosinophils 
and C. adaptive immune cells to the airways. D. Cytokine expression profile of CD4+ T cells 
(TH) in the airways. E. MFI for CD4+IL-13+ T cell population. F. Distribution of IL-17A+ 
and IL-17A− subpopulations of TH22 cells in the murine airways. Exposure groups - (white 
bars) Control, (grey bars) 104 spores, (black bars) 105 spores. MFI – mean fluorescence 
intensity. For all graphs (n=8-10).
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Figure 4. Accumulation of bi-functional CD4+ T cells in airways of mice inhaling A. fumigatus
Co-expression profile of cytokines on gated CD4+ T lymphocytes, A-C. IFN-γ/IL-13, D-F. 
IL-17A/IL-13 and G-I. IL-22/IL-13. Exposure groups - (white bars) Control, (grey bars) 104 
spores, (black bars) 105 spores. MFI – mean fluorescence intensity. For all graphs (n=8-10).
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Figure 5. Serum antibody responses and airway hyperreactivity in response to repeated 
inhalation of A. fumigatus spores
A. Pooled serum (n=3 mice; duplicate samples) IgE concentrations (ng/ml) determined by 
ELISA. Exposure groups - (white bars) Control, (grey bars) 104 spores, (black bars) 105 
spores. B. Ratio of serum IgG2a/IgG1. Exposure groups - (white bars) Control, (grey bars) 
104 spores, (black bars) 105 spores and (n=3 mice; duplicate samples). C. AHR analysis to 
varying concentrations (10, 25 and 50 mg/ml) of methacholine at 10 days post final 
exposure. Dose-dependent significant increase in AHR observed in mice repeatedly dosed to 
105 A. fumigatus spores and challenged with 50 mg/ml methacholine (n=3 mice). Exposure 
groups - (●) Control, (○) 104 spores, (▼) 105 spores.
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